Orchestra BioMed
OBIO
OBIO
39 hedge funds and large institutions have $121M invested in Orchestra BioMed in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
18
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$13.4M |
2 |
2
State Street
Boston,
Massachusetts
|
$2.61M |
3 |
3
Bank of America
Charlotte,
North Carolina
|
$415K |
4 |
4
Morgan Stanley
New York
|
$471K |
5 |
5
Charles Schwab
San Francisco,
California
|
$1.6M |